Skip to main content
Equibles
IDXX logo

IDXX · Idexx Laboratories Inc /De · Earnings Call Transcripts & Audio

Track IDXX — free

Use IDXX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IDXX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$522.19 -11.25 (-2.11%) At close · Sep 30
S&P 500 member Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$40.91B
Shares
78.78M
Volume · Sep 30 503.53K Avg daily vol (3M) 572.41K

Idexx Laboratories Inc Earnings Call Transcripts

Quarterly earnings calls for Idexx Laboratories Inc (IDXX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲3.9% $841.66M $180.94M '22 Q3 22-11-01 ▲3.4% $828.57M $172.21M '22 Q4 23-02-06 ▲7.6% $900.20M $214.05M '23 Q1 23-05-02 ▲9.7% $943.63M $224.24M '23 Q2 23-08-01 ▲8.8% $915.53M $212.23M '23 Q3 23-11-01 ▲8.8% $901.60M $194.52M '23 Q4 24-02-05 ▲7.1% $964.10M $235.58M '24 Q1 24-05-01 ▲6.4% $1.00B $203.30M '24 Q2 24-08-06 ▲6.6% $975.54M $232.84M '24 Q3 24-10-31 ▲5.8% $954.29M $216.15M '24 Q4 25-02-03 ▲3.6% $998.43M $242.68M '25 Q1 25-05-01 ▲10.6% $1.11B $293.99M '25 Q2 25-08-04 ▲13.3% $1.11B $274.61M '25 Q3 25-11-03 ▲14.3% $1.09B $248.19M '25 Q4 26-02-02 ▲14.3% $1.14B $278.45M '26 Q1 26-05-05 LATEST ▲9.7% $1.22B $338.41M '26 Q2 26-08-04
Conference
Investor event
2026-09-14
Idexx Laboratories Inc (IDXX) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-04
Idexx Laboratories Inc (IDXX) Q2 2026 Earnings Call Transcript
Confident tone CAG Diagnostics Recurring Revenue Premium Instrument Placements & InView DX International Growth
Revenue
$1.22B
▲ 9.7% YoY
Gross margin
64.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-05
Idexx Laboratories Inc (IDXX) Q1 2026 Earnings Call Transcript
Confident tone Companion Animal Diagnostics (CAG) Recurring Revenue Guidance Raise / Full-Year Outlook Premium Instrument Placements
Revenue
$1.14B
▲ 14.3% YoY
Gross margin
63.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-02
Idexx Laboratories Inc (IDXX) Q4 2025 Earnings Call Transcript
Confident tone Premium Instrument Placements (InVue DX, Catalyst, etc.) Software / SaaS (Velo, PIMs) 2026 Financial Guidance and Margin Expansion
Revenue
$1.09B*
▲ 14.3% YoY
Gross margin
60.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-03
Idexx Laboratories Inc (IDXX) Q3 2025 Earnings Call Transcript
Confident tone IDEXX Cancer Dx Adoption Premium Instrument Placements and Installed Base CAG Diagnostics Recurring Revenue Growth
Revenue
$1.11B
▲ 13.3% YoY
Gross margin
61.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-04
Idexx Laboratories Inc (IDXX) Q2 2025 Earnings Call Transcript
Confident tone CAG Diagnostic Recurring Revenue Growth IDEXX Cancer Dx Launch Profitability and Margin Expansion
Revenue
$1.11B
▲ 10.6% YoY
Gross margin
62.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
Idexx Laboratories Inc (IDXX) Q1 2025 Earnings Call Transcript
Positive tone IDEXX inVue Dx platform launch U.S. clinical visit headwinds Organic revenue growth and execution
Revenue
$998.43M
▲ 3.6% YoY
Gross margin
62.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-03
Idexx Laboratories Inc (IDXX) Q4 2024 Earnings Call Transcript
Confident tone Organic revenue growth Innovation / new product launches Operating margin and gross margin
Revenue
$954.29M*
▲ 5.8% YoY
Gross margin
59.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-31
Idexx Laboratories Inc (IDXX) Q3 2024 Earnings Call Transcript
Positive tone CAG diagnostic recurring revenue IDEXX In View / In Vue analyzer launch US macro and sector headwinds
Revenue
$975.54M
▲ 6.6% YoY
Gross margin
61.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Idexx Laboratories Inc (IDXX) Q2 2024 Earnings Call Transcript
Positive tone Innovation and inVue launch CAG diagnostic recurring revenue U.S. clinical visit headwinds
Revenue
$1.00B
▲ 6.4% YoY
Gross margin
61.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
Idexx Laboratories Inc (IDXX) Q1 2024 Earnings Call Transcript
Positive tone CAG Diagnostic recurring revenue growth Premium instrument placements and installed base U.S. clinical visit softness and macro headwinds
Revenue
$964.10M
▲ 7.1% YoY
Gross margin
61.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-05
Idexx Laboratories Inc (IDXX) Q4 2023 Earnings Call Transcript
Confident tone CAG Diagnostic Recurring Revenue Growth Veterinary Software and Diagnostic Imaging 2024 Financial Guidance
Revenue
$901.60M*
▲ 8.8% YoY
Gross margin
58.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Idexx Laboratories Inc (IDXX) Q3 2023 Earnings Call Transcript
Revenue
$915.53M
▲ 8.8% YoY
Gross margin
59.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Idexx Laboratories Inc (IDXX) Q2 2023 Earnings Call Transcript
Revenue
$943.63M
▲ 9.7% YoY
Gross margin
60.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Idexx Laboratories Inc (IDXX) Q1 2023 Earnings Call Transcript
Revenue
$900.20M
▲ 7.6% YoY
Gross margin
60.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-06
Idexx Laboratories Inc (IDXX) Q4 2022 Earnings Call Transcript
Revenue
$828.57M*
▲ 3.4% YoY
Gross margin
58.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-01
Idexx Laboratories Inc (IDXX) Q3 2022 Earnings Call Transcript
Revenue
$841.66M
▲ 3.9% YoY
Gross margin
60.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Idexx Laboratories Inc (IDXX) Q2 2022 Earnings Call Transcript
Revenue
$860.55M
▲ 4.2% YoY
Gross margin
59.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
Idexx Laboratories Inc (IDXX) Q1 2022 Earnings Call Transcript
Revenue
$836.55M
▲ 7.6% YoY
Gross margin
59.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-02
Idexx Laboratories Inc (IDXX) Q4 2021 Earnings Call Transcript
Revenue
$801.09M*
▲ 11.1% YoY
Gross margin
57.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Idexx Laboratories Inc (IDXX) Q3 2021 Earnings Call Transcript
Revenue
$810.42M
▲ 12.3% YoY
Gross margin
58.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-30
Idexx Laboratories Inc (IDXX) Q2 2021 Earnings Call Transcript
Revenue
$826.14M
▲ 29.6% YoY
Gross margin
59.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Idexx Laboratories Inc (IDXX) Q1 2021 Earnings Call Transcript
Revenue
$777.71M
▲ 24.2% YoY
Gross margin
60.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-02
Idexx Laboratories Inc (IDXX) Q4 2020 Earnings Call Transcript
Revenue
$720.94M*
▲ 19.1% YoY
Gross margin
56.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Idexx Laboratories Inc (IDXX) Q3 2020 Earnings Call Transcript
Revenue
$721.79M
▲ 19.2% YoY
Gross margin
58.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-31
Idexx Laboratories Inc (IDXX) Q2 2020 Earnings Call Transcript
Revenue
$637.59M
▲ 2.8% YoY
Gross margin
59.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-30
Idexx Laboratories Inc (IDXX) Q1 2020 Earnings Call Transcript
Revenue
$626.34M
▲ 8.7% YoY
Gross margin
57.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-01-31
Idexx Laboratories Inc (IDXX) Q4 2019 Earnings Call
Revenue
$605.45M
▲ 10.2% YoY
Gross margin
54.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–28 of 28 earnings calls
Key facts CIK 874716 CUSIP 45168D104 13F (30d) 21 filings 17 filers Visit website Investor relations